Evaluation effect of Curcumin in patients with Primary Dysmenorrhea

Study of the effect of Curcumin in patients with Primary Dysmenorrhea

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180404039187N8

Enrollment

Registered

2020-10-07

Start date

2020-08-11

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group:curcuma 500 mg twice daily from 2 days before menstruation until third day of mensuration for 2 months. Intervention 2: Control group: routine treatment which includ

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients with Primary Dysmenorrhea Aged 18 to 35 years old Having at least four recent consecutive painful menstrual cycles during the past six months Bleeding of 3 to 7 days during the menstruation

Exclusion criteria

Exclusion criteria: Taking contraceptives within the past two months Using intra-uterine device or drugs containing Curcumin within the past six months Smoking an alcohol consumption Malignancy

Design outcomes

Primary

Measure	Time frame
Severity of pain during menstruation. Timepoint: before intervention and 1, 2 months after intervention. Method of measurement: visual analogue scale.;Needs of NSAIDs. Timepoint: before intervention and 1, 2 months after intervention. Method of measurement: DN4 Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElnaz Shaseb

Tabriz University of Medical Sciences

Elnaz_shaseb_64@yahoo.com0098144933344197

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026